本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MAIA Biotechnology Inc.

2.00
-0.1000-4.76%
盤前2.030.0300+1.50%08:51 EDT
成交量:20.96萬
成交額:41.44萬
市值:5,917.46萬
市盈率:-1.91
高:2.04
開:2.02
低:1.90
收:2.10
資料載入中...
2023/04/20

重要事件披露

8-K - Current report
2023/04/18

SEC問詢函

Form CORRESP - Correspondence
2023/04/18

SEC問詢函

Form CORRESP - Correspondence
2023/04/18

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/18

重要事件披露

8-K - Current report
2023/04/11

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/11

重要事件披露

8-K - Current report
2023/04/07

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/04

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/24

重要事件披露

8-K - Current report
2023/03/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/17

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

重要事件披露

8-K/A [Amend] - Current report
2023/02/13

重要事件披露

8-K - Current report
2023/02/13

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/06

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2023/02/06

重要事件披露

8-K - Current report